Spotify Creator's New Business: 300,000 People Booked for Appointments
Translated from Polish, summarized and contextualized by DistantNews.
At a glance
- Spotify founder Daniel Ek is launching a new venture, Neko Health, focused on revolutionizing disease prevention through affordable, full-body health scans.
- Neko Health aims to democratize the 'longevity' trend by offering comprehensive diagnostics at a significantly lower cost than existing luxury services.
- The company has seen immense demand, with 300,000 people on a waiting list for its clinics in Stockholm, London, Manchester, Birmingham, and a forthcoming location in New York.
Daniel Ek, the billionaire founder of Spotify, is venturing into a new industry with Neko Health, a company poised to transform disease prevention. Developed over eight years with engineer Hjalmar Nilsonne, Neko Health offers comprehensive, affordable health check-ups aimed at detecting diseases in their earliest stages, or even before they manifest.
Neko Health taps into the growing 'longevity' trend, popularized by celebrities and Silicon Valley figures. While longevity treatments have largely been exclusive to the wealthy, Ek and Nilsonne aim to make advanced preventative care accessible to a broader population. A full-body scan at Neko Health costs 300 euros, a fraction of the price of similar high-end services.
The company utilizes artificial intelligence to democratize the field of preventative medicine, which traditionally relies on full-body scans. Neko Health also seeks to alleviate the burden on national healthcare systems. Since opening its first clinic in Stockholm in February 2023, Neko Health has expanded to London, Manchester, and Birmingham, with a new clinic planned for New York.
The demand for Neko Health's services is extraordinary. By early 2025, 100,000 people were on waiting lists across Europe. With the upcoming New York opening, that number has surged to 300,000 globally. Hjalmar Nilsonne described the service as "affordable luxury," delivering high-quality care at an accessible price point. The company is heavily investing in AI to automate and streamline diagnostic processes, further reducing costs.
I think we are currently positioned in the category of affordable luxury, delivering very high-quality services, but at a price that someone who is not a tycoon can afford.
Originally published by Rzeczpospolita in Polish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.